Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
43.82 CHF | -0.50% |
|
+1.43% | +18.48% |
07-08 | Sandoz Group AG, Q1 2025 Sales/ Trading Statement Call, Apr 30, 2025 | |
07-08 | Deutsche Bank Remains Cautious on Pharmaceutical Sector Ahead of Earnings Season | FW |
Capitalization | 23.79B 20.32B 18.97B 17.54B 32.56B 2,041B 36.47B 227B 86.26B 952B 89.24B 87.4B 3,493B | P/E ratio 2025 * |
28.9x | P/E ratio 2026 * | 19.8x |
---|---|---|---|---|---|
Enterprise value | 27.36B 23.37B 21.81B 20.17B 37.44B 2,348B 41.94B 261B 99.2B 1,095B 103B 101B 4,017B | EV / Sales 2025 * |
2.5x | EV / Sales 2026 * | 2.33x |
Free-Float |
95.68% | Yield 2025 * |
1.32% | Yield 2026 * | 1.76% |
More valuation ratios
* Estimated data
More news
Last Transcript: Sandoz Group AG
More recommendations
More press releases
More news
1 day | -0.50% | ||
1 week | +1.43% | ||
Current month | +1.43% | ||
1 month | +0.05% | ||
3 months | +39.68% | ||
6 months | +17.03% | ||
Current year | +18.48% |
1 week | 42.47 | ![]() | 44.2 |
1 month | 42.01 | ![]() | 44.41 |
Current year | 26.25 | ![]() | 45.1 |
1 year | 26.25 | ![]() | 45.1 |
3 years | 22.7 | ![]() | 45.1 |
5 years | 22.7 | ![]() | 45.1 |
10 years | 22.7 | ![]() | 45.1 |
Manager | Title | Age | Since |
---|---|---|---|
Richard Saynor
CEO | Chief Executive Officer | 58 | 2018-12-31 |
Director of Finance/CFO | 57 | 2024-06-30 | |
Chief Tech/Sci/R&D Officer | 58 | 2025-05-31 |
Director | Title | Age | Since |
---|---|---|---|
Karen Hübscher
BRD | Director/Board Member | 62 | 2023-07-31 |
Gilbert Ghostine
CHM | Chairman | 65 | 2023-02-28 |
Urs Riedener
BRD | Director/Board Member | 60 | 2023-07-31 |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
-0.50% | +1.43% | +31.11% | - | 23.79B | ||
+0.14% | +0.40% | +7.54% | +95.15% | 46.77B | ||
+0.97% | -2.11% | -3.38% | +37.04% | 23.82B | ||
+0.44% | -1.33% | +0.57% | +59.88% | 14.01B | ||
-1.06% | -2.94% | -15.96% | +165.88% | 11.53B | ||
-2.89% | -4.92% | +66.48% | +69.11% | 6.99B | ||
+0.26% | +0.78% | +38.30% | +102.28% | 6.98B | ||
-.--% | +0.14% | - | - | 6.79B | ||
-1.32% | +2.95% | +33.15% | +366.06% | 6.02B | ||
-.--% | -1.95% | - | - | 5.73B | ||
Average | -0.40% | -0.69% | +19.73% | +127.92% | 15.24B | |
Weighted average by Cap. | -0.11% | -0.44% | +12.64% | +98.91% |
2025 * | 2026 * | |
---|---|---|
Net sales | 10.93B 9.34B 8.71B 8.06B 14.96B 938B 16.75B 104B 39.62B 437B 40.99B 40.15B 1,605B | 11.6B 9.9B 9.24B 8.55B 15.87B 995B 17.78B 111B 42.04B 464B 43.49B 42.6B 1,703B |
Net income | 813M 695M 648M 600M 1.11B 69.78B 1.25B 7.77B 2.95B 32.55B 3.05B 2.99B 119B | 1.23B 1.05B 977M 904M 1.68B 105B 1.88B 11.71B 4.44B 49.06B 4.6B 4.5B 180B |
Net Debt | 3.57B 3.05B 2.84B 2.63B 4.88B 306B 5.47B 34.08B 12.94B 143B 13.38B 13.11B 524B | 3.24B 2.77B 2.59B 2.39B 4.44B 278B 4.97B 30.99B 11.76B 130B 12.17B 11.92B 476B |
More financial data
* Estimated data
Employees
22,049
Sector
Pharmaceuticals
Calendar
Date | Price | Change | Volume |
---|---|---|---|
25-07-09 | 44.01 CHF | -0.07% | 17,530 |
25-07-08 | 44.04 CHF | +0.75% | 851,649 |
25-07-07 | 43.71 CHF | +0.21% | 620,932 |
25-07-04 | 43.62 CHF | +1.92% | 678,173 |
25-07-03 | 42.80 CHF | +0.42% | 564,526 |
Delayed Quote Swiss Exchange, July 09, 2025 at 03:01 am
More quotesSell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
55.25USD
Average target price
54.13USD
Spread / Average Target
-2.03%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- SDZ Stock
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition